These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 90742

  • 1. [Clinical application of NK 631, a new derivative of bleomycin (author's transl)].
    Asahi M.
    Jpn J Antibiot; 1979 Jul; 32(7):744-50. PubMed ID: 90742
    [Abstract] [Full Text] [Related]

  • 2. [Clinical experience with NK 631 in malignant tumors of skin (author's transl)].
    Nobe O, Kubo H, Yoshii K, Tashiro M.
    Jpn J Antibiot; 1979 Mar; 32(3):463-9. PubMed ID: 86628
    [Abstract] [Full Text] [Related]

  • 3. [Treatment with NK 631 (new bleomycin analog) of oral and maxillofacial cancer (author's transl)].
    Nakanishi K, Miki T, Adachi K, Teranobu O, Shimada K.
    Jpn J Antibiot; 1979 Feb; 32(2):282-90. PubMed ID: 86625
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experience with NK 631 (pepleomycin) for malignant tumors of skin (author's transl)].
    Seki T, Shimada S, Ohara K.
    Jpn J Antibiot; 1979 Feb; 32(2):278-81. PubMed ID: 86624
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical effects of NK 631 in malignant tumors of the oral cavity (author's transl)].
    Kawahira K, Dohhara Y, Sugihara K, Yamada K, Fujinami Y, Saku T, Yamashita S.
    Jpn J Antibiot; 1979 Jan; 32(1):138-48. PubMed ID: 84884
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experience with pepleomycin (NK 631) (author's transl)].
    Hashimoto K, Shioda S, Amagasa T, Shimizu M, Sato O, Ito H, Fujibayashi T, Soda T.
    Jpn J Antibiot; 1979 Mar; 32(3):451-62. PubMed ID: 86627
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Preoperative application of NK 631 for carcinoma of oral cavity (author's transl)].
    Yamamoto E, Sunakawa H, Kohama GI.
    Jpn J Antibiot; 1979 Feb; 32(2):253-8. PubMed ID: 86621
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].
    Baumgartner G.
    Wien Klin Wochenschr; 1973 Oct 19; 85(42):686-92. PubMed ID: 4128921
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical application of NK 631 in the treatment of cancer of the tongue and the floor of the mouth (author's transl)].
    Hayashida K, Watanabe H, Ito M, Nakashima T, Toriya Y, Hiroto I, Jingu K, Hayabuchi N.
    Jpn J Antibiot; 1979 Apr 19; 32(4):509-15. PubMed ID: 88531
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical application of NK-631, a new bleomycin to head-and-neck malignant tumors (author's transl)].
    Makimoto K, Nagahara K.
    Jpn J Antibiot; 1979 Jan 19; 32(1):121-8. PubMed ID: 84882
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.